Quantifying the Effect of Supplementation with Algae and Its Extracts on Glycolipid Metabolism: A Meta-Analysis of Randomized Controlled Trials

Abstract

Aims: The effect of algae and its extract supplementation on glycolipid metabolism has not been finalized. Therefore, the purpose of the meta-analyses was to assess the effects of its supplementation on glycolipid metabolism concentration. Methods: We have systematically searched PubMed, Web of Science, the Cochrane Library and Embase to identify randomized controlled trials (RCTs) that investigated the impact of algae and its extracts supplementation on glycolipid metabolism. Effect size analysis was performed using weighted mean difference (WMD) and 95% CI between the methods of the experiment group and the control group. Subgroup analyses were performed to explore the possible influences of study characteristics. Publication bias and sensitivity analysis were also performed. Results: A total of 27 RCTs (31 trials) with 1221 participants were finally selected for the meta-analysis. The algae and its extract intervention significantly decreased glycosylated hemoglobin (HbA1c, WMD = −0.18%; 95% CI: −0.27 to −0.10; p < 0.001), high-density lipoprotein cholesterol (HDL-C, WMD = −0.22 mmol/L; 95% CI: −0.38 to −0.06; p = 0.008), and triglycerides (TC, WMD = −0.31 mmol/L; 95% CI: −0.37 to −0.25; p < 0.001) levels and increased insulin (WMD = 6.05 pmol/mL; 95% CI: 4.01 to 8.09; p < 0.001) levels. It did not significantly change the blood glucose, homeostasis model assessment-insulin resistance index (HOMA-IR), 2-h post-meal blood glucose (2hPBG) and other lipid profiles. Subgroup analyses based on the duration of intervention and subjects demonstrated that the intervention of algae and its extracts for 10 weeks or fewer and more than 40 subjects decreased TC levels (p < 0.05). Moreover, the intervention reduced TC and 2hPBG concentrations for East Asians (p < 0.05). Conclusions: Our findings provided evidence that algae and its extract interventions were beneficial for the regulation of human glycolipid metabolism. More precise RCTs on subjects are recommended to further clarify the effect of algae, seaweed polysaccharide, seaweed polypeptide, algae polyphenol and its products intervention on glycolipid metabolism.

Using polyphenols as a relevant therapy to diabetes and its complications, a review

“…It provided overall improvements to lipid metabolism, reduced inflammation, reduced or inhibited lipid accumulation, reduced or inhibited adipogenesis by downregulating genes involved in the process and activating AMPK, reduced insulin resistance and reduced the formation of ROS and lipid peroxidation both in humans and mice models of hyperlipidemia. These effects were also reported other recent reviews on marine polyphenols (Venkatesan et al 2019;Fernando et al 2020; Mateos, P erez-Correa, and Dom ınguez 2020).A meta-analysis by Ding et al (2020) of randomized clinical trials found that algae supplementation significantly reduced HDL and triglycerides levels but not LDL or total cholesterol.…”

“…CA was shown to increase the release of insulin on chronically hyperglycemic pancreatic b-cells (Bhattacharya et al 2014) and, as a supplement to a standard mouse diet, it was able to increase the levels of plasma insulin (Jung et al 2006;Chao et al 2010) and decreased the levels of blood glucose. Insulin levels in humans can also be improved by algae supplementation (Ding et al 2020).…”

Platycodin D ameliorates hyperglycaemia and liver metabolic disturbance in HFD/STZ-induced type 2 diabetic mice

“…4 It is well known that abnormalities in glucose and lipid metabolism often occur together, and numerous studies have shown that simultaneous control of glucose and lipid metabolism in the liver plays a very important role in the treatment of diabetes. 5…”

Anti-Diabetic Effects of Ethanol Extract from Sanghuangporous vaninii in High-Fat/Sucrose Diet and Streptozotocin-Induced Diabetic Mice by Modulating Gut Microbiota

“…Thus, failure to detect and prevent T2DM in time may lead to serious complications, and pose a huge threat to life and health [ 49 ]. Usually, abnormal glucose metabolism and lipid metabolism often occur in parallel [ 50 ]. Afterward, consistent with previous studies [ 51 , 52 ], there were notable ( p < 0.001) increases in the levels of TC (13.82 ± 2.18 mmol/L), TG (2.11 ± 0.22 mmol/L), LDL-c (3.62 ± 0.56 mmol/L), TBA (11.84 ± 2.69 μmol/L), and FFA (2.24 ± 0.26 μmol/mL) in the DC group compared to the NC group, whereas there were no meaningful differences regarding HDL-c levels among the groups ( Figure 2 A–F).…”